Paper Details

  1. Home
  2. Paper Details

Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: Results of 2 phase 3, randomized, clinical trials.

Author: BhatiaNeal D, Del RossoJames Q, GoldLinda Stein, HooperDeirdre, KircikLeon, NahmWalter K, StuartIain

Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

FMX103 1.5% topical minocycline foam was efficacious for moderate to severe papulopustular rosacea and maintained a favorable safety profile.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Efficacious topical medications for rosacea are needed. FMX103 1.5% is a novel topical minocycline foam that may have therapeutic benefits in treating rosacea while minimizing systemic adverse effects due to its topical route of delivery. OBJECTIVE: To determine the efficacy, safety, an...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.jaad.2020.01.043

データ提供：米国国立医学図書館（NLM）

Topical Minocycline Foam for Rosacea: A New Frontier in Treatment

The world of [Dermatology] is constantly searching for effective treatments for skin conditions like [Rosacea]. This study explores the potential of [Minocycline 1.5% foam], a novel topical formulation, in treating [Papulopustular Rosacea]. Imagine a desert traveler facing a fierce sandstorm: This topical minocycline foam could be a protective shield against the inflammation and discomfort of rosacea.

Minocycline Foam: A Promising New Option for Rosacea

The study, based on two phase 3 clinical trials, found that [Minocycline 1.5% foam] significantly reduced the number of inflammatory lesions in individuals with [Papulopustular Rosacea], compared to a placebo. The foam was also well-tolerated, with no serious adverse events reported. It's like finding a refreshing oasis in a parched desert: This topical minocycline foam provides a safe and effective way to manage the symptoms of rosacea.

Hope for Individuals with Rosacea

This research offers hope for individuals struggling with [Rosacea]. Topical minocycline foam presents a potentially effective and well-tolerated treatment option, providing a new frontier in the management of this common skin condition.

Dr.Camel's Conclusion

This study sheds light on the potential of [Minocycline 1.5% foam] as a promising new treatment for [Papulopustular Rosacea]. Its effectiveness and safety profile offer a valuable option for individuals seeking relief from the symptoms of this condition. Further research is needed to explore the long-term efficacy and potential applications of this topical formulation, but the initial results are encouraging for individuals seeking a safe and effective way to manage rosacea.

Date :
  1. Date Completed 2020-11-24
  2. Date Revised 2020-11-24
Further Info :

Pubmed ID

32004648

DOI: Digital Object Identifier

10.1016/j.jaad.2020.01.043

Related Literature

Article Analysis
・Effects of minocycline topical
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.